The global market for Electrophoresis Reagents was estimated at US$1.2 Billion in 2023 and is projected to reach US$1.7 Billion by 2030, growing at a CAGR of 5.2% from 2023 to 2030.
What Factors Are Driving Growth in the Electrophoresis Reagents Market?
The growth in the electrophoresis reagents market is driven by several factors, including increased investment in genomics and proteomics research, rising demand for personalized medicine, and advancements in molecular diagnostics. As genomic research becomes more central to understanding diseases and developing targeted therapies, the need for high-quality electrophoresis reagents has increased significantly. Electrophoresis remains a core technique in sequencing, gene expression analysis, and biomarker discovery, making these reagents critical for advancing personalized medicine. The rapid expansion of biotechnology and pharmaceutical industries has further fueled demand, as electrophoresis reagents are used in drug development and quality control processes, ensuring that biological products meet safety and efficacy standards.
The growing prevalence of chronic diseases such as cancer, diabetes, and genetic disorders has also contributed to the increased use of electrophoresis in clinical diagnostics. Hospitals and diagnostic labs use electrophoresis reagents to identify disease markers, analyze protein levels, and detect genetic mutations, supporting early diagnosis and personalized treatment strategies. Moreover, advancements in capillary electrophoresis and automated systems have encouraged adoption among research institutes and clinical labs, as these technologies offer higher throughput, better resolution, and faster analysis times. The rise of academic research in fields like genomics, proteomics, and forensic science has further supported the market, with electrophoresis reagents being essential tools for basic and applied research.
Additionally, government funding and initiatives aimed at improving healthcare infrastructure and research capabilities, particularly in emerging economies, are creating new opportunities for growth in the electrophoresis reagents market. With ongoing innovations that enhance efficiency, safety, and specificity, the market is poised for sustained growth, driven by the increasing demand for precise molecular analysis across various sectors.
Key Insights:
Market Growth: Understand the significant growth trajectory of the Gels segment, which is expected to reach US$709.2 Million by 2030 with a CAGR of a 5.7%. The Dyes segment is also set to grow at 4.9% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, estimated at $313.8 Million in 2023, and China, forecasted to grow at an impressive 8.3% CAGR to reach $396.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Key Questions Answered:
How is the Global Electrophoresis Reagents Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?
Report Features:
Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players in the Global Electrophoresis Reagents Market such as Agilent Technologies, Biological Industries, Bio-Rad Laboratories, ELITechGroup, Expedeon and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 48 companies featured in this Global Electrophoresis Reagents market report include:
Agilent Technologies
Biological Industries
Bio-Rad Laboratories
ELITechGroup
Expedeon Ltd.
GE Healthcare
Lonza
Merck Millipore
PerkinElmer
Promega Corporation
QIAGEN
Randox Laboratories Ltd.
SERVA Electrophoresis
Takara BIO
Thermo Fisher Scientific
Key Attributes:
Report Attribute
Details
No. of Pages
96
Forecast Period
2023 – 2030
Estimated Market Value (USD) in 2023
$1.2 Billion
Forecasted Market Value (USD) by 2030
$1.7 Billion
Compound Annual Growth Rate
5.2%
Regions Covered
Global
Key Topics Covered:
1. MARKET OVERVIEW
World Market Trajectories
Global Economic Update
Electrophoresis Reagents – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Focus on Molecular Diagnostics Drives Demand for Electrophoresis Reagents
Increasing Applications in DNA Sequencing Propel Market for Electrophoresis Reagents
Expansion of Genomics Research Sustains Demand for Electrophoresis Reagents
Rising Use in Protein Analysis Strengthens Business Case for Reagent Adoption
Adoption in Biopharmaceutical Development Expands Addressable Market
Increased Focus on RNA Analysis Supports Electrophoresis Reagent Market
Trend Towards Automated Gel Electrophoresis Propels Demand for Specialized Reagents
Rising Application in Clinical Diagnostics Drives Reagent Adoption
Growing Use in Forensic Science Sustains Demand for Electrophoresis Reagents
Advancements in Capillary Electrophoresis Generate Market Expansion
Growing Need for High-Accuracy Protein Analysis Bodes Well for Electrophoresis Reagent Use
Expanding Use in Food and Beverage Testing Propels Reagent Demand
About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
